Testosterone patch approved in Denmark:
This article was originally published in Clinica
Executive Summary
The Swedish pharmaceutical company, Astra is distributing TheraTech's transdermal testosterone patch in Denmark after receiving Danish National Health Board approval this month. Known as Atmos in Scandinavia and as Androderm in the US and the UK, the patch is for the treatment of male hypogonadism, insufficient testosterone production. The patch received US FDA approval last September. It is marketed in the US and the UK by SmithKline Beecham (see Clinica No 722, p 20). Astra, which is based in Sodertalje, has been marketing the product in Sweden since August.